Single-dose Novel Selective alpha2c Antagonist Pharmaco-MRI Study in Healthy Volunteers
Clinical trial NCT03440021 · COMPLETED
Trial details
- NCT number
- NCT03440021
- Sponsor
- University of Cape Town
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2018-12-05
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.